Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Beam Therapeutics Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $122 Billion
- Q2 2025
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 13,300 shares of BEAM stock, worth $397,537. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,300
Previous 10,492
26.76%
Holding current value
$397,537
Previous $204,000
10.78%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BEAM
# of Institutions
245Shares Held
95.7MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$299 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$290 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$264 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$228 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$141 Million0.05% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $2.1B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...